(Q36541968)

14 August 2017

1 reference

title

INGN 201 (Advexin): adenoviral p53 gene therapy for cancer (English)

1 reference

14 August 2017

0 references

1 reference

Dmitry I Gabrilovich

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

823-832

1 reference

p53, the cellular gatekeeper for growth and division

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

The p53 tumor suppressor: critical regulator of life & death in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Multiple roles of the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Isolation of p53-target genes and their functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Efficacy of intraperitoneal adenovirus-mediated p53 gene therapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

The p53 network in lung carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Viral-mediated gene transfer for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

P53 gene replacement for cancer--interactions with DNA damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated p53 gene therapy for human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenoviral vector-mediated gene transfer: timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

Current standards of care in small-cell and non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.823

21 January 2018

Identifiers

DOI

10.1517/14712598.6.8.823

1 reference

14 August 2017

1 reference